News & Updates
Filter by Specialty:
Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients
05 Jan 2022
In patients with Kawasaki disease, every day that intravenous immunoglobulin (IVIG) treatment is delayed aggravates the risk of developing coronary artery aneurysms (CAA), a recent study has found.
Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients
05 Jan 2022Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021
For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.